HR 6524, the HIRE Act, extends the Work Opportunity Tax Credit (WOTC) through 2030 and adds a new provision to incentivize hiring individuals receiving Social Security disability benefits. The bill directly affects employers who hire people certified as eligible for disability insurance benefits under the Social Security Act within 60 days before employment. Key provisions include modifying the tax credit to cover "qualified social security disability insurance beneficiaries" and requiring certification by a local agency for eligibility. The changes apply to new hires beginning work after December 31, 2025, with the credit extension applying through 2030.
HRES 930 is a symbolic resolution designating December 8, 2025, as "Jimmy Lai Day" to honor Jimmy Lai's advocacy for free press, religious freedom, and democracy in Hong Kong. It calls on the People's Republic of China and Hong Kong authorities to release Jimmy Lai and other Hong Kong prodemocracy advocates detained under Hong Kong's National Security Law. The resolution does not create new laws or policies but expresses congressional support for Lai's work and condemns the imprisonment of those advocating for Hong Kong's freedoms. It directly affects U.S. diplomatic messaging toward China, not Hong Kong's legal system or residents.
HRES 932 is a symbolic resolution passed by the House of Representatives that condemns six specific members of Congress (including Senators Kelly and Slotkin and Representatives Crow, Deluzio, Goodlander, and Houlahan) for allegedly making statements that encouraged military and intelligence personnel to disobey orders from the President. The resolution claims these lawmakers falsely suggested the administration issued "illegal orders" and undermined the military chain of command, violating the Uniform Code of Military Justice (UCMJ). It does not create new laws or policies but formally denounces the lawmakers' statements as "dangerous and seditious rhetoric." As a procedural resolution, it has no binding effect on military conduct or policy.
The SAFE Chips Act of 2025 requires U.S. exporters to obtain government licenses before sending advanced computer chips to "foreign adversary countries" (including China, Hong Kong, and Macau) or to entities owned by such countries. It defines "advanced integrated circuits" using specific technical standards, such as high processing power (e.g., 4,800+ performance points) or bandwidth (e.g., 4,100+ gigabytes per second), excluding chips designed for data centers. The bill mandates license denials for these exports and allows the Commerce Secretary to update technical definitions after 30 months, with required Congressional briefings on national security impacts. This directly affects chip manufacturers and companies exporting to specified regions, imposing strict controls on advanced semiconductor trade.
The Back the Blue Act of 2025 creates new federal criminal offenses for killing or assaulting law enforcement officers, judges, and certain public safety personnel (including firefighters and first responders) while they are on duty or because of their official status. It increases penalties for these crimes, including minimum 10-year prison terms for killing officers and longer sentences for assaults causing serious injury, with the death penalty possible for killings. The bill also adds a "flight to avoid prosecution" provision for those fleeing to evade charges for killing officers, expands law enforcement officers' rights to carry firearms in certain circumstances, and limits federal habeas corpus relief for individuals convicted of killing law enforcement officers. This legislation directly affects law enforcement officers, judges, and public safety personnel, as well as individuals who commit violence against them.
This Senate resolution (SRES 525) condemns the Iranian government's ongoing, state-sponsored persecution of the Baha'i minority, citing decades of systemic abuses including executions, job dismissals, education bans, and property confiscations. It references UN reports and Human Rights Watch findings documenting Iran's violation of international human rights treaties, such as the Universal Declaration of Human Rights and the International Covenant on Civil and Political Rights. The resolution calls on Iran to immediately release imprisoned Baha'is, end discriminatory policies restricting their education and employment, and cease hate propaganda, while urging the U.S. President and Secretary of State to impose sanctions on Iranian officials responsible for these abuses.
The American Citizens First Act restricts federal benefits for noncitizens and strengthens immigration enforcement. It bars noncitizens from receiving most federal benefits, including welfare, food assistance, Medicaid (except emergency services), housing aid, and student loans. The bill also allows revoking citizenship for naturalized citizens convicted of violent protests or acts against the government, expands expedited removal for certain immigrants, and requires security reviews for Afghans admitted since 2021. Additionally, it automatically terminates temporary protected status for nationals from countries where the crime rate among them exceeds the national average by 20%, with semiannual crime rate reports to Congress.
This bill increases the tax exclusion for capital gains when selling a primary residence. It doubles the exclusion amount from $250,000 (for single filers) to $500,000 and from $500,000 (for married couples) to $1,000,000. The bill also adds an inflation adjustment for amounts after 2025, tying future increases to the cost-of-living adjustment. It directly affects homeowners who sell their primary residence and would otherwise owe tax on profits exceeding the previous limits. The changes apply to sales after the bill's enactment date.
The Rx ACCESS Act improves prescription drug access for TRICARE beneficiaries, including military service members, retirees, and their families, by establishing fair reimbursement standards for pharmacies and expanding medication choice. It requires pharmacies to be reimbursed at actual drug costs (or the national average drug cost for certain medications) plus a standard dispensing fee, while banning hidden fees like point-of-sale charges. Starting October 1, 2026, beneficiaries can choose how they receive non-generic medications for ongoing health conditions. The law also mandates annual audits to verify reimbursement fairness and ensure pharmacy networks provide accessible care, especially in rural and underserved areas.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
The CLEAR Act of 2025 limits legal challenges to energy projects by blocking repeated lawsuits about the same project's authorization. It establishes that once a court rules on any legal action concerning an energy project's authorization (like permits for electricity, fossil fuels, or critical minerals), no further lawsuits about that project can be filed - regardless of the parties or type of relief sought. The bill requires courts to remand procedural errors to agencies within 180 days and sets a 150-day deadline for filing challenges after authorization is public. Exceptions include post-completion violations or enforcement actions by government agencies. This primarily affects energy developers, federal/state agencies, and legal challengers by reducing litigation delays for projects already approved.
S 654 establishes a new External Provider Scheduling Program within the Department of Veterans Affairs (VA) to improve appointment scheduling for veterans using the Veterans Community Care Program. The program requires real-time technology allowing VA schedulers to view and book appointments with community care providers, directly affecting veterans who rely on non-VA care due to VA wait times. Key provisions mandate reducing referral-to-appointment wait times (measured in days) and scheduler processing time (days/hours), with full VA medical center implementation required by September 30, 2025. The VA must also submit annual progress reports to Congress through 2028.
